Search | CADTH

Showing 3431 - 3440 results of 3509

nusinersen (Spinraza) (Last Updated: Jun 12, 2020)

Request for Resubmission: Eligible (Decision Date: May 24, 2018)

Project Line:

Reimbursement Review

Project Status:

Complete

Contains:

Brand Name Manufacturer Submission Type Indications

fluticasone furoate/vilanterol (Breo Ellipta ) (Last Updated: Jun 18, 2020)

Project Line:

Reimbursement Review

Project Status:

Withdrawn

Contains:

Brand Name Manufacturer Submission Type Indications

Pembrolizumab (Keytruda) classical Hodgkin Lymphoma – Details (Keytruda) (Last Updated: Jan 22, 2018)

Project Line:

Reimbursement Review

Project Status:

Complete

Contains:

Brand Name Manufacturer Submission Type Indication

Canada’s Opioid Crisis: Delivering Robust Evidence to Guide Our Response (Last Updated: May 29, 2017)

CADTH is deeply concerned about the opioid crisis that is devastating communities, families, and individuals across Canada. In November 2016 we joined federal and jurisdictional ministries of health...

The Management of Insulin Administration and Blood Glucose Monitoring in Children with Type 1 Diabetes Mellitus: Guidelines (Last Updated: May 24, 2017)

Project Line:

Reference List

Mechanical Cardiopulmonary Resuscitation Devices for Cardiac Arrest: Clinical Effectiveness and Cost-Effectiveness (Last Updated: May 23, 2017)

Project Line:

Reference List

cyclosporine (Ikervis) (Last Updated: Mar 22, 2019)

Project Line:

Reimbursement Review

Project Status:

Withdrawn

Contains:

Brand Name Manufacturer Submission Type Indications

Intermittent Pneumatic Compression Devices for the Management of Lymphedema: A Review of Clinical Effectiveness and Guidelines (Last Updated: May 12, 2017)

Project Line:

Health Technology Review

CHAD65 and CHA2DS2-VASc Risk Stratification Tools for Patients with Atrial Fibrillation: A Review of Clinical Effectiveness and Guidelines (Last Updated: May 12, 2017)

Project Line:

Health Technology Review

Art Therapy for Patients with Cognitive Disabilities: Clinical Effectiveness (Last Updated: May 5, 2017)

Project Line:

Reference List

Current Filters

nusinersen (Spinraza) (Last Updated: Jun 12, 2020)

fluticasone furoate/vilanterol (Breo Ellipta ) (Last Updated: Jun 18, 2020)

Pembrolizumab (Keytruda) classical Hodgkin Lymphoma – Details (Keytruda) (Last Updated: Jan 22, 2018)

Canada’s Opioid Crisis: Delivering Robust Evidence to Guide Our Response (Last Updated: May 29, 2017)

The Management of Insulin Administration and Blood Glucose Monitoring in Children with Type 1 Diabetes Mellitus: Guidelines (Last Updated: May 24, 2017)

Mechanical Cardiopulmonary Resuscitation Devices for Cardiac Arrest: Clinical Effectiveness and Cost-Effectiveness (Last Updated: May 23, 2017)

cyclosporine (Ikervis) (Last Updated: Mar 22, 2019)

Intermittent Pneumatic Compression Devices for the Management of Lymphedema: A Review of Clinical Effectiveness and Guidelines (Last Updated: May 12, 2017)

CHAD65 and CHA2DS2-VASc Risk Stratification Tools for Patients with Atrial Fibrillation: A Review of Clinical Effectiveness and Guidelines (Last Updated: May 12, 2017)

Art Therapy for Patients with Cognitive Disabilities: Clinical Effectiveness (Last Updated: May 5, 2017)